Kensuke Moriwaki

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Panel data analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 08, 2022
Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan.

Xiuting Mo, Kensuke Moriwaki, Kosuke Morimoto

|Jan 23, 2021
Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan.

Kensuke Moriwaki, Saki Uechi, Takaaki Fujiwara

Pageof 1

Frequent Collaborators